David S. Tierney - Aug 21, 2024 Form 4 Insider Report for CATALYST PHARMACEUTICALS, INC. (CPRX)

Role
Director
Signature
/s/ David S. Tierney
Stock symbol
CPRX
Transactions as of
Aug 21, 2024
Transactions value $
-$241,305
Form type
4
Date filed
8/23/2024, 05:00 PM
Previous filing
Apr 10, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CPRX Common stock, par value $0.001 per share Options Exercise $60.2K +15K +4.3% $4.01 364K Aug 21, 2024 Direct
transaction CPRX Common stock, par value $0.001 per share Sale -$301K -15K -4.12% $20.10 349K Aug 21, 2024 Direct F1, F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CPRX Options to purchase common stock Options Exercise $0 +15K +8.62% $0.00 189K Aug 22, 2024 Common Stock 15K $4.01 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Shares were sold on the open market for personal reasons and not as a result of any disagreement with the Company.
F2 Represents a weighted average price for the shares sold. Shares were sold in various lots ranging from $20.00 to $20.485 per share.
F3 Options vested in three annual tranches beginning on January 2, 2019.